Maxigen Biotech Inc. (TPE:1783)
Taiwan · Delayed Price · Currency is TWD 40.90
+0.90 (2.25%)
Aug 19, 2026, 1:30 PM CST
Maxigen Biotech Market Cap
Maxigen Biotech has a market cap or net worth of 3.59 billion as of August 19, 2026. Its market cap has decreased by -6.76% in one year.
Market Cap
3.59B
Enterprise Value
2.69B
Revenue
837.44M
Ranking
n/a
PE Ratio
12.43
Stock Price
40.90
ChartMarket Cap Chart
Since December 23, 2013, Maxigen Biotech's market cap has increased from 3.53B to 3.59B, an increase of 1.76%. That is a compound annual growth rate of 0.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 3.59B | -6.54% |
| Dec 31, 2025 | 3.84B | -12.06% |
| Dec 31, 2024 | 4.36B | 1.40% |
| Dec 29, 2023 | 4.30B | 6.65% |
| Dec 30, 2022 | 4.04B | 0.99% |
| Dec 30, 2021 | 4.00B | 151.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medeon Biodesign | 6.48B |
| Pacific Hospital Supply | 5.60B |
| Formosa Optical Technology | 5.36B |
| St.Shine Optical | 4.77B |
| Bionime | 4.40B |
| SciVision Biotech | 3.71B |
| ICARES Medicus | 3.45B |
| Nang Kuang Pharmaceutical | 3.23B |